Exostar Secure Access Manager (SAM) is an identity and access management platform designed specifically for clinical trial operations. It provides centralized access management for sponsors and research sites, supporting over 821,000 users across 36,000 sites with SSO access to 122+ clinical trial applications. Key capabilities include: - Single Sign-On (SSO): Users authenticate once to access all connected clinical trial applications, reducing credential sprawl and password-related risks. - Delegated Administration: Sponsor and site teams can manage user access independently without relying on centralized IT, accelerating onboarding and resolving access issues faster. - Automated Access Provisioning: Rules-based workflows replace manual processes (spreadsheets, emails) to assign user access accurately and efficiently. - Real-Time Reporting: Dashboards surface user activity, access trends, and training compliance metrics to support operational decisions and audit preparation. - Continuous Compliance Monitoring: SAM maintains an audit trail of access history, training status, and system usage to support regulatory reporting and ensure only authorized users retain access. The platform is targeted at pharmaceutical companies and clinical research sites seeking to streamline study start-up, reduce IT burden, and maintain compliance with industry regulations. It is used by over 25 leading pharmaceutical companies.